Evidence map›Paper›PMID 39226043›Full record

ArticleACS applied materials & interfaces2024

Precision Treatment of Colon Cancer Using Doxorubicin-Loaded Metal-Organic-Framework-Coated Magnetic Nanoparticles.

Honglin Jiang, Qing Bao, Tao Yang, Mingying Yang, Chuanbin Mao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS applied materials & interfaces, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Honglin JiangSchool of Materials Science & Engineering, Zhejiang University, Hangzhou, Zhejiang 310027, China.
Qing BaoSchool of Materials Science & Engineering, Zhejiang University, Hangzhou, Zhejiang 310027, China.
Tao YangSchool of Materials Science & Engineering, Zhejiang University, Hangzhou, Zhejiang 310027, China.
Mingying YangKey Laboratory of Silkworm and Bee Resource Utilization and Innovation of Zhejiang Province, Institute of Applied Bioresource Research, College of Animal Science, Zhejiang University, Hangzhou, Zhejiang 310058, China.ORCID 0000-0003-1256-6514
Chuanbin MaoDepartment of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 999077, China.ORCID 0000-0002-8142-3659

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the limited efficacy and evident side effects of traditional chemotherapy drugs attributed to their lack of specificity and selectivity, novel strategies are essential for improving cancer treatment outcomes. Here, we successfully engineered Fe

Indexed as

Colonic NeoplasmsDoxorubicinMagnetite NanoparticlesMetal-Organic FrameworksAnimalsAntibiotics, AntineoplasticCell Line, TumorDrug CarriersHumansImidazolesMiceMice, Inbred BALB CZeolitesAntibiotics, AntineoplasticDoxorubicinDrug CarriersImidazolesMagnetite NanoparticlesMetal-Organic FrameworksZeolitesZIF-8 metal-organic frameworkacid responsivenesscardiotoxicitycolon cancermagnetic targetingmetal−organic frameworks (MOFs)

Identifiers

PMID39226043
PMCPMC11420861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.